Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs.
Zhang X, Sun S, Miao Y, Yuan Y, Zhao W, Li H, Wei X, Huang C, Hu X, Wang B, Xu H, Zhang W, Gao X, Song J, Zheng J, Zhang Q.
Zhang X, et al. Among authors: zhang q, zhang w.
J Cancer Res Clin Oncol. 2022 Dec;148(12):3511-3520. doi: 10.1007/s00432-022-04248-y. Epub 2022 Aug 12.
J Cancer Res Clin Oncol. 2022.
PMID: 35962287